WanderingBlast
Full Member
- Joined
- Apr 26, 2023
- Messages
- 11
- Reaction score
- 2
I’m a year 3 heme/onc fellow, headed into a BMT attending position next year. I have never been good at solid oncology. Nor have I particularly liked it. But I was told it can limit future job options to board in heme only. So I always planned to take both boards.
I recently got my ASCO ITE back and scored badly (7th percentile for my fellowship year). This is in part due to the fact that I haven’t started studying, and haven’t done any solid oncology clinics in over a year and a half. I also never seem to have gotten the hang of solid oncology in that way I did with heme malignancies. The majority of my clinical experience in fellowship has been in malignant and classical hematology and BMT.
I’m trying to decide if:
1) I should just single board in heme. My career path is presently academic BMT. If I end up tiring of academics I always thought I could move to a community-based/academic affiliated large practice that would allow me to focus on heme/BMT. I realize those jobs are rare, but I have seen that they do exist. I don’t know if not being onc boarded would limit my chances at such a position though.
2) Study hard and take onc boards this year (Nov), and heme boards next year (2024). The upside of this is I can use the minute breast/lung knowledge I’ve managed to hold on to. The downside is that I don’t know that 6 months of board studying before Nov will be enough to get me a passing onc score.
3) Take heme boards this year, onc boards next year. This approach will allow me to study for boards in a field actually applicable to my immediate practice. Which I suspect will be helpful for the initial adjustment to attendinghood. The downside is that I will need to specifically carve out time to study onc during this next year, and I might forget some of what I learned in solid onc clinics during fellowship.
I’m leaning towards #3 right now. But part of me also just wants to get onc over with. I’d appreciate any advice you all may have.
I recently got my ASCO ITE back and scored badly (7th percentile for my fellowship year). This is in part due to the fact that I haven’t started studying, and haven’t done any solid oncology clinics in over a year and a half. I also never seem to have gotten the hang of solid oncology in that way I did with heme malignancies. The majority of my clinical experience in fellowship has been in malignant and classical hematology and BMT.
I’m trying to decide if:
1) I should just single board in heme. My career path is presently academic BMT. If I end up tiring of academics I always thought I could move to a community-based/academic affiliated large practice that would allow me to focus on heme/BMT. I realize those jobs are rare, but I have seen that they do exist. I don’t know if not being onc boarded would limit my chances at such a position though.
2) Study hard and take onc boards this year (Nov), and heme boards next year (2024). The upside of this is I can use the minute breast/lung knowledge I’ve managed to hold on to. The downside is that I don’t know that 6 months of board studying before Nov will be enough to get me a passing onc score.
3) Take heme boards this year, onc boards next year. This approach will allow me to study for boards in a field actually applicable to my immediate practice. Which I suspect will be helpful for the initial adjustment to attendinghood. The downside is that I will need to specifically carve out time to study onc during this next year, and I might forget some of what I learned in solid onc clinics during fellowship.
I’m leaning towards #3 right now. But part of me also just wants to get onc over with. I’d appreciate any advice you all may have.
Last edited: